+91 22 24172311
Sections
Search
Subscribe
Equity
Venture Capital
Private Equity
M&A

Mergers & Acquisitions | 17 August 2012

KKR, Novartis, Pfizer In Race To Acquire Strides' Unit

by Paritosh Gajjar
 
@Paritosh
Strides Arcolabs' injectable-drugs unit, @Agila_Specialties Private Limited is up for sale and 'serious bidders' for the asset are Novartis and @Pfizer_Limited along with U.S buyout fund KKR, ET stated.

Strides is expecting to receive anywhere between $1.6-2 Bn for the unit - more than twice its market value.

Strides provides Pfizer with generic versions of off-patent drugs through a partnership announced in 2010.

Orbit Corp To Raise Funds - Selling Multiple Projects

Orbit Corp is planning to sell multiple planned projects in Mumbai to raise funds and reduce debt, according to Mint.

Read More...

Atishay Infotech To Go Public Through SME Platform

Mumbai based Atishay Infotech Limited has filed DRHP on BSE SME platform for the issue of 2.3 Mn equity shares at a price of INR 16 per unit aggregating to INR 37.1 Cr. The issue constitutes 26.41% of the paid up equity share capital of the company.

Read More...
CONTACT US
Info@DealCurry.com
+91 22 24172311
A 311, 3rd Floor, AntopHill Warehousing Company,
Near Dosti Acres
Wadala(E),
Mumbai 400037
   
 
CLIENTS
USEFUL LINKS
SOLUTIONS
Copyright © EagleEye Research & Media Pvt. Ltd. 2009 All Rights Reserved - Interactive multimedia analysis platform for financial markets.
Site map |Terms of Use |Privacy Policy
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.